News
Trump, Tariff
Digest more
Australia’s pharmaceutical benefits scheme is not up for negotiation, says the federal government in the face of ramped-up US ...
Johnson & Johnson (NYSE:JNJ) is set to kick off the second quarter pharma earnings on Wednesday, with investors focusing on ...
Drugmaker Swedish Orphan Biovitrum AB’s Chief Executive Officer Guido Oelkers said he doesn’t think tariff threats on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results